🔴 Neuronetics is trading 5% down today amid a 1.33% healthcare-sector decline

Neuronetics is trading at $2.42, down 5.09%, amid broader healthcare-sector weakness; no clear company-specific catalyst surfaced for September 29, 2026.

• Healthcare is down 1.33%, while the S&P 500 is down 0.35% and the Dow is down 0.66%.
• Reuters reports investors are weighing elevated bond yields and oil prices, adding to broader market headwinds.